Rock Springs Capital Management LP

Position in PHVS — Pharvaris N.V.

CIK 1595725 Baltimore, MD

Position in PHVS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$22,419,355

+$4,183,048 QoQ

Shares Held

648,333

+0.4% QoQ

Ownership

0.923%

of shares outstanding

% of Portfolio

1.09%

of 13F equity value

Holder Rank

#26

of 124 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Rock Springs Capital Management LP holds $1,502,002,537 across 70 Biotechnology names. PHVS ranks #18 (1.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	1,105,210	$206,983,728
2	TVTX	Travere Therapeutics, Inc.	2,179,069	$123,792,909
3	MDGL	Madrigal Pharmaceuticals, Inc.	174,999	$93,965,713
4	MIRM	Mirum Pharmaceuticals, Inc.	798,145	$93,438,835
5	RYTM	Rhythm Pharmaceuticals, Inc.	692,598	$76,899,155
6	KYMR	Kymera Therapeutics, Inc.	453,156	$51,963,398
7	ARGX	Argenx SE	52,750	$48,939,867
8	ASND	Ascendis Pharma A/S	168,750	$45,009,000

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$22,419,355	648,333	+0.4%	Shares	Sole	2026-08-14
2026-03-31	$18,236,307	645,533	+3.6%	Shares	Sole	2026-05-15
2025-12-31	$17,299,405	623,402	0.0%	Shares	Sole	2026-02-17
2025-09-30	$15,553,879	623,402	0.0%	Shares	Sole	2025-11-14
2025-06-30	$10,971,875	623,402	0.0%	Shares	Sole	2025-08-14
2025-03-31	$9,787,411	623,402	-19.6%	Shares	Sole	2025-05-15
2024-12-31	$14,859,261	775,131	+2.4%	Shares	Sole	2025-02-14
2024-09-30	$14,018,362	756,931	0.0%	Shares	Sole	2024-11-14
2024-06-30	$14,230,302	756,931	+0.5%	Shares	Sole	2024-08-14
2024-03-31	$17,400,073	752,924	—	Shares	Sole	2024-05-15
No filing history on record for this holder in this stock.